When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PTI - Proteostasis up 6% premarket ahead of CF data presentation
Yumanity Therapeutics Inc Com
Nano cap Proteostasis Therapeutics (NASDAQ:PTI) is up 6% premarket on modest volume ahead of a presentation of results from an ex vivo study of its cystic fibrosis transmembrane conductance regulator (CFTR) modulators in organoids from individuals with CF who are ineligible for current standard-of-care CFTR modulator therapies due to their genotype (~2,300 European adults). The data, based on samples from up to 500 patients, are being presented at the Keystone Symposia on Tissue Organoids in Vancouver, BC.
More news on: Proteostasis Therapeutics, Inc., Healthcare stocks news, Stocks on the move,